HQY Healthequity Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HQY

Price (delayed)

$82.35

Market cap

$6.34B

P/E Ratio

2,745

Dividend/share

N/A

EPS

$0.03

Enterprise value

$7.13B

Sector: Healthcare
Industry: Health Information Services
Website: https://healthequity.com/

Highlights

HQY's revenue has surged by 84% year-on-year and by 3.1% since the previous quarter
The gross profit has surged by 67% year-on-year and by 2% since the previous quarter
HQY's net income has surged by 117% since the previous quarter but it has dropped by 94% year-on-year
HQY's EPS has surged by 110% since the previous quarter but it has dropped by 97% year-on-year
HQY's gross margin is down by 9% year-on-year

Key stats

What are the main financial stats of HQY
Market
Shares outstanding
76.99M
Market cap
$6.34B
Enterprise value
$7.13B
Valuations
Price to earnings (P/E)
2,745
Price to book (P/B)
4.67
Price to sales (P/S)
8.46
EV/EBIT
150.47
EV/EBITDA
44.73
EV/Sales
9.55
Earnings
Revenue
$746.6M
EBIT
$47.4M
EBITDA
$159.45M
Free cash flow
$92.5M
Per share
EPS
$0.03
Free cash flow per share
$1.21
Book value per share
$17.63
Revenue per share
$9.73
TBVPS
$7.22
Balance sheet
Total assets
$2.66B
Total liabilities
$1.3B
Debt
$1.09B
Equity
$1.36B
Working capital
$244.67M
Liquidity
Debt to equity
0.81
Current ratio
2.62
Quick ratio
2.4
Net debt/EBITDA
4.97
Margins
EBITDA margin
21.4%
Gross margin
57.3%
Net margin
0.4%
Operating margin
6.7%
Efficiency
Return on assets
0.1%
Return on equity
0.3%
Return on invested capital
3.6%
Return on capital employed
1.9%
Return on sales
6.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HQY stock price

How has the Healthequity stock price performed over time
Intraday
-1.48%
1 week
3.81%
1 month
-9.52%
1 year
8.78%
YTD
18.13%
QTD
18.13%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$746.6M
Gross profit
$428.1M
Operating income
$50.14M
Net income
$3.28M
Gross margin
57.3%
Net margin
0.4%
HQY's net income has surged by 117% since the previous quarter but it has dropped by 94% year-on-year
The net margin has surged by 115% since the previous quarter but it has dropped by 97% year-on-year
HQY's revenue has surged by 84% year-on-year and by 3.1% since the previous quarter
The gross profit has surged by 67% year-on-year and by 2% since the previous quarter

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
P/E
2,745
P/B
4.67
P/S
8.46
EV/EBIT
150.47
EV/EBITDA
44.73
EV/Sales
9.55
HQY's EPS has surged by 110% since the previous quarter but it has dropped by 97% year-on-year
The stock's P/B is 37% below its 5-year quarterly average of 7.4 but 33% above its last 4 quarters average of 3.5
The equity has grown by 33% YoY
HQY's revenue has surged by 84% year-on-year and by 3.1% since the previous quarter
The stock's price to sales (P/S) is 34% more than its last 4 quarters average of 6.3 but 32% less than its 5-year quarterly average of 12.5

Efficiency

How efficient is Healthequity business performance
HQY's return on sales has surged by 200% since the previous quarter but it has dropped by 64% year-on-year
The ROE has soared by 117% from the previous quarter but it has plunged by 96% YoY
The ROA has soared by 113% from the previous quarter but it has plunged by 98% YoY
HQY's ROIC has shrunk by 76% YoY

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 104% higher than its total liabilities
HQY's quick ratio is up by 41% year-on-year and by 9% since the previous quarter
Healthequity's current ratio has increased by 37% YoY and by 5% QoQ
The debt is 19% smaller than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.